About Us


Founded by three of the world’s leading authorities in neuroscience, medicine and computer science, Mindstrong Health is redefining behavioral healthcare by redefining how care providers will diagnose and manage brain disorders.

Mindstrong’s technology will – for the first time - give patients and providers a seamless and instantaneous method to objectively and continuously measure mood, cognition, and behavior in the home and work environment, delivering insights not possible with traditional clinical, neuropsychological, and imaging techniques.

Mindstrong builds on one of the founder’s digital biomarker platform developed over years of extensive R&D.

Our Values : Science That Makes a Difference.
  • We value curiosity, high quality data, rigorous analysis, innovation
  • We believe that scientific excellence is the foundation for improved diagnostics and therapeutics
  • Our goals are defined by the needs of patients with serious illnesses – we build products for objective measurement but we also attend to subjective experience
Measuring Success: Changing Minds and Fixing brains.
  • Our goals are to reduce disability, hospitalization, ER visits, and suicide
  • We seek to shift healthcare from reactive to proactive
  • Ultimately we will transform care from “diagnose and treat” to “predict and preempt”


Mindstrong’s founders are redefining the management and treatment of neuropsychiatric and neurodegenerative disorders based on passive, continuous and ecological measurements of brain function.


Mindstrong’s executive team is comprised of passionate leaders with unrivaled experience in data science, neuroscience, software engineering, health information systems, and life science business development.

Board of Directors

Mindstrong's Board of Directors bring deep experience working at the intersection of academia and industry.

Rick Klausner, MD

Co-Founder and Executive Chairman, Mindstrong Health

Virginia McFerran

Partner, Optum Ventures

Tom Insel, MD

Co-Founder and President, Mindstrong Health

CEO and Founder, Foresite Capital

Robert Epstein, MD

CEO, Epstein Health

Paul Dagum, MD PHD

Founder and Chief Executive Officer, Mindstrong Health

Scientific Advisory Board

Mindstrong's Scientific Advisory Board provides leading scientific oversight and guidance.

Sir Philip Campbell, PhD

Editor-in-Chief, Nature,
part of Nature Publishing Group

Ian Gotlib, PhD

Professor and Chair, Psychology,
Stanford University

Sophia Vinogradov, MD

Professor and Head, Department of Psychiatry,
University of Minnesota

Amit Etkin, MD, PhD

Associate Professor of Psychiatry andBehavioral Science,
Stanford University

Michael Frumkin, MS

Director, Google Accelerated Science;

Ethical-Legal-Social Implications (ELSI) Board

Mindstrong's ELSI Board ensures that digital biomarkers for the diagnosis and treatment of mental health conditions earns and maintains public trust.

Paul Gionfriddo

President & CEO, Mental Health America

Brandon Staglin

Director, One Mind

Nev Jones, PhD

Director of Research, Felton Institute

Nicole Martinez, PhD, JD

Postdoctoral Fellow, Stanford Bioethics

Sharon Terry, MA

President & CEO, Genetic Alliance

Katherine Switz, MBA

Founder & Executive Director, The Stability Network

Monica Luke

Executive Director, Living Assistance Fund


Mindstrong’s investors have launched some of the most transformative biotechnology and healthcare companies in neuropsychiatry and neurodegeneration.

Intellectual Property

Mindstrong has developed and patented a biomarker panel that measures brain function from interaction patterns captured passively and continuously from human-computer interfaces found in ubiquitous mobile technology.


Join our Team

Mindstrong Health is building a team of the strongest minds in the business. If youre looking for an exciting career, join the team.